Skip to main content

Investor RelationsWealth Management:  CA  |  UK  |  AU

Menu

BEIJING | CHINA

Partnering to deliver
global solutions
tailored to your unique needs

Transactions

Our corporate finance solutions are tailored to our clients’ strategic goals and delivered based on in depth expertise across a wide range of sectors globally. We have a strong track record, participating in 187 transactions and raising C$19.5 Billion on behalf of our clients in Q3/20211.2.

Filter our transactions* using the categories below:

Dye & Durham
C$630m
February 2021

Dye & Durham

Lead Left Bookrunner (Follow-on & Convertible Debenture)
TECHNOLOGY EQUITY CAPITAL MARKETS CANADA
Osisko Mining
US$70m
February 2021

Osisko Mining

Lead Left Bookrunner (Private Placement)
METALS AND MINING EQUITY CAPITAL MARKETS US
MicroStrategy Incorporated
US$1b
February 2021

MicroStrategy Incorporated

Co-Manager (144a Convert)
TECHNOLOGY EQUITY CAPITAL MARKETS US
View transaction detail
Travere Therapeutics Inc.
US$175m
February 2021

Travere Therapeutics Inc.

Lead Manager (Follow-on)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Jushi
C$75m
February 2021

Jushi

Co-Lead Bookrunner (Equity Financing)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS CANADA
Revive Therapeutics Ltd.
C$23m
February 2021

Revive Therapeutics Ltd.

Co-Lead Bookrunner (Equity Financing)
CANNABIS HEALTHCARE EQUITY CAPITAL MARKETS CANADA
Bioventus Inc.
US$120m
February 2021

Bioventus Inc.

Lead Manager (IPO)
HEALTHCARE EQUITY CAPITAL MARKETS US
Jet2.com
£422m
February 2021

Jet2.com

Joint Global Coordinator, Joint Bookrunner and Joint Broker (Placing and Retail Offer)
INDUSTRIALS/AEROSPACE & DEFENSE AEROSPACE & DEFENCE CORPORATE BROKING EQUITY CAPITAL MARKETS UK
Kaledio
US$69m
February 2021

Kaledio

Lead Manager (Follow-On)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail
Enthusiast Gaming
C$51m
February 2021

Enthusiast Gaming

Sole Bookrunner (Bought Deal)
GAMING TECHNOLOGY EQUITY CAPITAL MARKETS CANADA
Viant Technology, Inc.
US$288m
February 2021

Viant Technology, Inc.

Co-Manager (IPO)
TECHNOLOGY EQUITY CAPITAL MARKETS US
View transaction detail
Rhythm Pharmaceuticals, Inc.
US$173m
February 2021

Rhythm Pharmaceuticals, Inc.

Lead Manager (Follow-On)
HEALTHCARE EQUITY CAPITAL MARKETS US
View transaction detail